Machado-Joseph disease

Jump to navigation Jump to search
Machado-Joseph disease
ICD-10 G11.1
ICD-9 334.2
OMIM 109150
DiseasesDB 31961
MeSH D017827

WikiDoc Resources for Machado-Joseph disease

Articles

Most recent articles on Machado-Joseph disease

Most cited articles on Machado-Joseph disease

Review articles on Machado-Joseph disease

Articles on Machado-Joseph disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Machado-Joseph disease

Images of Machado-Joseph disease

Photos of Machado-Joseph disease

Podcasts & MP3s on Machado-Joseph disease

Videos on Machado-Joseph disease

Evidence Based Medicine

Cochrane Collaboration on Machado-Joseph disease

Bandolier on Machado-Joseph disease

TRIP on Machado-Joseph disease

Clinical Trials

Ongoing Trials on Machado-Joseph disease at Clinical Trials.gov

Trial results on Machado-Joseph disease

Clinical Trials on Machado-Joseph disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Machado-Joseph disease

NICE Guidance on Machado-Joseph disease

NHS PRODIGY Guidance

FDA on Machado-Joseph disease

CDC on Machado-Joseph disease

Books

Books on Machado-Joseph disease

News

Machado-Joseph disease in the news

Be alerted to news on Machado-Joseph disease

News trends on Machado-Joseph disease

Commentary

Blogs on Machado-Joseph disease

Definitions

Definitions of Machado-Joseph disease

Patient Resources / Community

Patient resources on Machado-Joseph disease

Discussion groups on Machado-Joseph disease

Patient Handouts on Machado-Joseph disease

Directions to Hospitals Treating Machado-Joseph disease

Risk calculators and risk factors for Machado-Joseph disease

Healthcare Provider Resources

Symptoms of Machado-Joseph disease

Causes & Risk Factors for Machado-Joseph disease

Diagnostic studies for Machado-Joseph disease

Treatment of Machado-Joseph disease

Continuing Medical Education (CME)

CME Programs on Machado-Joseph disease

International

Machado-Joseph disease en Espanol

Machado-Joseph disease en Francais

Business

Machado-Joseph disease in the Marketplace

Patents on Machado-Joseph disease

Experimental / Informatics

List of terms related to Machado-Joseph disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Machado-Joseph disease is a type of spinocerebellar ataxia caused by a mutation in the ATXN3 gene.

It causes ophthalmoplegia and mixed sensory and cerebellar ataxia

It is also known as Spinocerebellar ataxia type 3.

It was first identified in 1972.[1]

Machado-Joseph Disease is a rare, inherited disease that causes lack of muscle control. Chromosome 14 is where the gene that is responsible for MJD is located.

Based on DNA studies, MJD is the most widespread, autosomal dominant inherited form of ataxia in the world.

Symptoms

Symptoms of MJD are spasticity, difficulty with speech and swallowing, weakness in arms and legs, clumsiness, frequent urination and involuntary eye movements. Symptoms can being in early adolescence and they get worse over time. There is no cure for Machado-Joseph Disease, however, there are treatments available for some symptoms. For example, spasticity can be reduced with Antispasmodic drugs, such as baclofen. Eventually, MJD leads to paralysis however, intellectual functions usually remain the same.

Prognosis

Life expectancy ranges with people who have the disease. A normal life expectancy is expected in patients with a mild form of MJD. Those with severe forms of MJD are expected to live only to their mid-thirties. The cause of death of those who die early is often aspiration pneumonia.

Pathophysiology

MJD has lengthy irregular repetition of the DNA genetic code located within a gene on chromosome 14q. The code "CAG" is repeated and produces a mutated protein called ataxin-3. In affected cells, this protein piles up and assembles intranuclear inclusion bodies.

These insoluble spheres are located in the nucleus of the cell. These spheres conflict with the normal activity of the nucleus and induce the cell to degenerate and die.

Classification

The types of MJD are characterized by the onset and age and range of symptoms.

  • Type I is distinguished by arrival between the ages of 10 and 30 years of age. It usually has fast development and severe rigidity and dystonia.
  • Type II typically begins between 20 and 50 years of age. It has an intermediate progression and causes symptoms that include spasticity, exaggerated reflex responses and spastic gait.
  • Type III MJD has a slow progression. Symptoms include muscle twitching, tingling, cramps, unpleasant sensations such as numbness, pain in the feet, hands and limbs and muscle atrophy. Patients typically have an onset between the ages of 40 and 70. Nearly all patients experience a decline in their vision such as blurred vision, double vision, inability to control eye movements, and loss of capability to distinguish color. Some patients also experience Parkinson’s-like symptoms.

Diagnosis

MJD can be diagnosed by recognizing the symptoms of the disease and by taking a family history. Physicians ask patients questions about the kind of symptoms relatives with the disease had, the progression and harshness of symptoms, and the ages of onset in family members. The best diagnosis of MJD can be made only with a genetic test.

References

  1. Nakano KK, Dawson DM, Spence A (1972). "Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts". Neurology. 22 (1): 49–55. PMID 5061839.

External links


Template:WikiDoc Sources